Fig. 15 | Scientific Reports

Fig. 15

From: Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson’s disease

Fig. 15The alternative text for this image may have been generated using AI.

Effects of ACE inhibitors on the TGF-β levels and the TGF-β levels in the cilazapril groups. Cilazapril dose-dependently suppressed the increase in the TGF-β levels caused by 6-OHDA administration and decreased the TGF-β levels to levels close to those of the control group at high doses (C-1.28, C-2.56). (b) TGF-β levels in the benazepril groups: benazepril effectively reduced the increase in the TGF-β level caused by 6-OHDA, with a significant reduction at low doses (B-0.04, B-0.08). The values are presented as the means ± standard errors of the means (*p < 0.05).

Back to article page